MB-106,Cyclophosphamide
fortress biotech,mustang bio
[]
#eha2023: one patient who achieved a complete response has remained in remission for 22 months, with an immunoglobulin m (igm) level that decreased rapidly to the normal range after treatment with mb-106 and has remained normal since. $mbio 
Mustang Bio, a Fortress Biotech company, is focused on the development of novel immunotherapies and gene therapies in areas of unmet need.